<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Clinical assessment of diabetes mellitus and lipid disorders: history, examination, retinopathy classification, and investigations.">
    <title>Chapter 17: Diabetes & Metabolic Disorders | Hutchison's Clinical Methods</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
    
    <!-- MathJax Configuration -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true
        },
        svg: { fontCache: 'global' }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <!-- Skip Link for Accessibility -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Reading Progress Bar -->
    <div class="reading-progress-container" aria-hidden="true">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Theme Toggle -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode" title="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="page-wrapper">
        <!-- Floating Mini-TOC -->
        <aside class="floating-toc" id="floating-toc" aria-label="On this page">
            <div class="floating-toc-header">
                <span class="floating-toc-icon">üìë</span>
                <span>On this page</span>
            </div>
            <nav class="floating-toc-nav">
                <ul class="floating-toc-list">
                    <!-- Populated by JS -->
                </ul>
            </nav>
        </aside>

        <div class="container">
            <article class="document-article" role="main" id="main-content">
                <!-- Top Navigation -->
                <nav class="document-nav" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="../index.html" class="nav-button nav-button--toc" aria-label="Table of Contents">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">Contents</span>
                        </a>
                        
                        <a href="16-endocrine.html" class="nav-button nav-button--prev" aria-label="Previous section">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Prev</span>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span class="progress-current">17</span>
                                <span class="progress-separator">/</span>
                                <span class="progress-total">21</span>
                            </div>
                            <div class="progress-bar-container" aria-hidden="true">
                                <div class="progress-bar-fill" style="width: 80.9%;"></div>
                            </div>
                            <span class="progress-label">Diabetes & Metabolic</span>
                        </div>
                        
                        <a href="18-kidneys.html" class="nav-button nav-button--next" aria-label="Next section">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>

                <!-- Breadcrumb -->
                <nav class="breadcrumb" aria-label="Breadcrumb">
                    <ol class="breadcrumb-list">
                        <li class="breadcrumb-item"><a href="../index.html">Home</a></li>
                        <li class="breadcrumb-item"><a href="../index.html#section-4">Clinical Specialties</a></li>
                        <li class="breadcrumb-item active" aria-current="page">Chapter 17</li>
                    </ol>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span class="badge-icon">üî¨</span>
                        <span class="badge-text">Section 4</span>
                    </div>
                    <h1 class="document-title">Diabetes and Other Metabolic Disorders</h1>
                    <div class="title-meta">
                        <span class="meta-item">
                            <span class="meta-icon">‚úçÔ∏è</span>
                            <span>Tahseen A. Chowdhury</span>
                        </span>
                        <span class="meta-item">
                            <span class="meta-icon">‚è±Ô∏è</span>
                            <span>45 min read</span>
                        </span>
                    </div>
                </header>

                <!-- Main Content Area -->
                <div class="content-wrapper">
                    
                    <section id="introduction" class="content-section">
                        <h2>Introduction</h2>
                        <p>The study of metabolism began as long ago as the fifteenth century BC, with the first description of diabetes in the Ebers Papyrus. Metabolic diseases comprise a variety of disorders encompassing a number of medical specialties. They contribute significantly to mortality and morbidity, predominantly from cardiovascular disease. Diabetes and metabolic disorders have become more prevalent in both developed and developing countries, leading to a significant burden of chronic disease and complications related to those diseases. This increased prevalence is related to excessive calorific intake coupled with reduced physical activity. Whereas in the past metabolic diseases such as diabetes were deemed diseases of the rich, in developed countries they are now frequently diseases of lower social class, as access to healthier foods may be expensive and difficult.</p>
                        <p>The major metabolic disorders considered in this chapter are:</p>
                        <ul>
                            <li>diabetes mellitus and the metabolic syndrome</li>
                            <li>lipid disorders.</li>
                        </ul>
                    </section>

                    <section id="diabetes-mellitus" class="content-section">
                        <h2>Diabetes mellitus and the metabolic syndrome</h2>
                        <p>Diabetes is a Greek word meaning 'a passer through; a siphon', and mellitus derives from the Greek word for 'sweet'. The Greeks named it thus due to the excessive amounts of urine produced by sufferers which attracted insects because of its glucose content. The ancient Chinese tested for diabetes by observing whether ants were attracted to a person's urine.</p>
                        <p>Diabetes mellitus is the most common metabolic disorder encountered in clinical practice. It is strongly linked to obesity. Diabetes mellitus is characterized by abnormal carbohydrate and lipid homoeostasis, leading to elevation in plasma glucose, or hyperglycaemia, and abnormality of serum lipids, or dyslipidaemia. Glucose homoeostasis is modulated mainly by the release of insulin from the islet cells ($\beta$ cells) of the pancreas. Diabetes develops as a result of a variable combination of absolute insulin deficiency as a result of pancreatic islet cell dysfunction and tissue insulin resistance due to reduced cellular responsiveness to insulin.</p>

                        <div class="table-wrapper">
                            <div class="table-header">
                                <span class="table-icon">üìã</span>
                                <span class="table-caption">Table 17.1 The WHO classification of diabetes mellitus</span>
                            </div>
                            <div class="table-container">
                                <table class="content-table">
                                    <thead>
                                        <tr>
                                            <th>Type</th>
                                            <th>Common subtypes/pathogenesis</th>
                                            <th>Treatment</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Type 1</strong></td>
                                            <td>Destruction of pancreatic islet cells leading to insulin deficiency</td>
                                            <td>Insulin</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Type 2</strong></td>
                                            <td>Ranges from predominantly insulin resistance with relative insulin deficiency (often associated with obesity) to predominantly insulin deficiency</td>
                                            <td>Diet/oral hypoglycaemic agents/insulin</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Other types</strong></td>
                                            <td>Genetic defects of $\beta$-cell function (MODY), Genetic defects of insulin action, Diseases of exocrine pancreas, Endocrinopathies, Drug induced</td>
                                            <td>Variable</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Gestational</strong></td>
                                            <td>Diabetes first diagnosed during pregnancy</td>
                                            <td>Diet/insulin</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>

                        <div class="table-wrapper">
                            <div class="table-header">
                                <span class="table-icon">‚öñÔ∏è</span>
                                <span class="table-caption">Table 17.2 Clinical differences between type 1 and type 2 diabetes</span>
                            </div>
                            <div class="table-container">
                                <table class="content-table">
                                    <thead>
                                        <tr>
                                            <th>Feature</th>
                                            <th>Type 1</th>
                                            <th>Type 2</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr><td><strong>Ketosis prone</strong></td><td>Yes</td><td>Uncommon</td></tr>
                                        <tr><td><strong>Insulin requirement</strong></td><td>Yes (absolute deficiency)</td><td>Often later in disease</td></tr>
                                        <tr><td><strong>Onset</strong></td><td>Acute</td><td>Often insidious</td></tr>
                                        <tr><td><strong>Obese</strong></td><td>Uncommon</td><td>Common</td></tr>
                                        <tr><td><strong>Age at onset</strong></td><td>Usually < 30</td><td>Usually > 30</td></tr>
                                        <tr><td><strong>Family history</strong></td><td>10%</td><td>30%</td></tr>
                                        <tr><td><strong>Twin concordance</strong></td><td>30-50%</td><td>90-100%</td></tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>

                        <h3 id="diagnosis">Diagnosis</h3>
                        <p>The diagnostic criteria for disorders of glucose metabolism based on the 75-g oral glucose tolerance test are shown in Table 17.3. Note that glycosuria itself (glucose in the urine) is not a reliable diagnostic test for diabetes mellitus.</p>

                        <div class="table-wrapper">
                            <div class="table-header">
                                <span class="table-icon">üî¨</span>
                                <span class="table-caption">Table 17.3 The oral glucose tolerance test</span>
                            </div>
                            <div class="table-container">
                                <table class="content-table">
                                    <thead>
                                        <tr>
                                            <th>Condition</th>
                                            <th>Fasting Plasma Glucose</th>
                                            <th>2-hour Plasma Glucose</th>
                                            <th>Random Plasma Glucose</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Diabetes</strong></td>
                                            <td>$\geq 7.0$ mmol/l</td>
                                            <td>$\geq 11.1$ mmol/l</td>
                                            <td>$\geq 11.1$ mmol/l</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Impaired Tolerance (IGT)</strong></td>
                                            <td>$< 7.0$ mmol/l</td>
                                            <td>7.8 - 11.0 mmol/l</td>
                                            <td>-</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Impaired Fasting (IFG)</strong></td>
                                            <td>6.1 - 6.9 mmol/l</td>
                                            <td>$< 7.8$ mmol/l</td>
                                            <td>-</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                            <p class="text-sm text-tertiary mt-2">Note: In the absence of symptoms, diabetes should only be diagnosed on the basis of two abnormal glucose results.</p>
                        </div>

                        <h3 id="metabolic-syndrome">Metabolic Syndrome</h3>
                        <p>It has long been recognized that many people have a clustering of risk factors for cardiovascular disease. Thus, the term metabolic syndrome has been coined. People with the syndrome are at high risk of diabetes and cardiovascular disease.</p>

                        <div class="content-card">
                            <h4 class="nav-title" style="margin-bottom: var(--space-4);">Box 17.2 IDF Definition of Metabolic Syndrome</h4>
                            <p><strong>Central Obesity:</strong> Waist $\geq 94$ cm (Europid men) or $\geq 80$ cm (Europid women).</p>
                            <p class="mt-2 mb-2"><strong>PLUS any two of:</strong></p>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker">1</span>Raised Triglyceride: $> 1.7$ mmol/l (150 mg/dl)</li>
                                <li class="list-item"><span class="list-marker">2</span>Reduced HDL: $< 1.03$ mmol/l (men) or $< 1.29$ mmol/l (women)</li>
                                <li class="list-item"><span class="list-marker">3</span>Raised BP: systolic $> 130$ or diastolic $> 85$ mmHg</li>
                                <li class="list-item"><span class="list-marker">4</span>Raised Fasting Plasma Glucose: $> 5.6$ mmol/l (100 mg/dl)</li>
                            </ul>
                        </div>
                    </section>

                    <section id="presenting-symptoms" class="content-section">
                        <h2>Presenting symptoms of diabetes</h2>
                        <p>Many people with type 2 diabetes may be asymptomatic at diagnosis. The cardinal symptoms of diabetes mellitus are weight loss, polyuria and polydipsia, and their presence should always result in an immediate test for blood glucose and urine for ketones.</p>

                        <h3 id="polyuria-polydipsia">Polyuria, polydipsia and nocturia</h3>
                        <p>Acute hyperglycaemia causes increased urine excretion (polyuria) and, as a result, excessive thirst and water ingestion (polydipsia). These presenting symptoms of diabetes mellitus are also termed osmotic symptoms. Nocturia is also common in patients presenting with osmotic symptoms of diabetes.</p>

                        <div class="content-card">
                            <h4 class="nav-title" style="margin-bottom: var(--space-4);">Table 17.4 Causes of polyuria</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><strong>Osmotic diuresis:</strong> Diabetes mellitus, chronic renal failure, drugs</li>
                                <li class="list-item"><span class="list-marker"></span><strong>Polydipsia:</strong> Psychogenic</li>
                                <li class="list-item"><span class="list-marker"></span><strong>Lack of ADH:</strong> Cranial diabetes insipidus</li>
                                <li class="list-item"><span class="list-marker"></span><strong>Failure of response to ADH:</strong> Nephrogenic diabetes insipidus</li>
                            </ul>
                        </div>

                        <h3 id="weight-loss">Weight loss and lethargy</h3>
                        <p>Loss of more than 5% of total body weight should be considered clinically important. Weight loss is a common presenting symptom in people with type 1 diabetes. Loss of weight in diabetes is predominantly due to renal glucose loss. This weight loss usually occurs despite a normal appetite and dietary intake.</p>

                        <h3 id="skin-problems">Skin problems</h3>
                        <p>Dermatological manifestations of diabetes are common at diagnosis. Skin infections, such as staphylococcal infection leading to boils, carbuncles or abscesses, which are often recurrent, may occur. Oral and genital candidiasis can also be presenting features. Genital candidiasis in women leads to a thick white discharge and vaginal soreness. Similarly, in men it can lead to a severe balanitis.</p>

                        <h3 id="visual-disturbance">Visual disturbance</h3>
                        <p>Hyperglycaemia can lead to blurred vision, owing to osmotic changes within the aqueous humour of the lens of the eye. The symptom usually settles once normoglycaemia is achieved.</p>
                    </section>

                    <section id="history-taking" class="content-section">
                        <h2>Other important aspects of a diabetic history</h2>
                        
                        <h3 id="family-history">Family history</h3>
                        <p>A history of diabetes in first-degree relatives is a potent risk factor for diabetes. Type 2 diabetes appears to have a stronger genetic component than type 1. A family history of premature cardiovascular disease is also important.</p>

                        <h3 id="lifestyle">Diet and lifestyle history</h3>
                        <p>The cornerstone of management of diabetes is lifestyle. Enquire about regularity of meals, content of fatty/greasy foods, fruit/vegetables, sugar, salt, and alcohol intake. The smoking history is of paramount importance.</p>

                        <h3 id="home-testing">Home glucose testing</h3>
                        <p>In a patient previously diagnosed with diabetes, assess his self-monitoring of glucose (Fig. 17.1).</p>
                        
                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../assets/images/image-20251213-86d82389.jpeg" alt="Home glucose testing" class="figure-image" loading="lazy">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption"><strong>Figure 17.1</strong> Home glucose testing is an important part of diabetes care.</figcaption>
                        </figure>
                    </section>

                    <section id="complications" class="content-section">
                        <h2>Symptoms of complications of diabetes</h2>
                        <p>Chronic complications of diabetes mellitus can be usefully subdivided into large blood vessels (macrovascular), small blood vessels (microvascular) and others.</p>

                        <div class="table-wrapper">
                            <div class="table-header">
                                <span class="table-icon">‚ö†Ô∏è</span>
                                <span class="table-caption">Table 17.5 Chronic complications of diabetes</span>
                            </div>
                            <div class="table-container">
                                <table class="content-table">
                                    <thead>
                                        <tr>
                                            <th>Type</th>
                                            <th>Complications</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Macrovascular</strong></td>
                                            <td>Coronary heart disease<br>Peripheral vascular disease<br>Cerebrovascular disease</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Microvascular</strong></td>
                                            <td>Retinopathy (non-proliferative, proliferative, maculopathy)<br>Nephropathy<br>Neuropathy (peripheral sensory, autonomic, mononeuropathy)</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Other</strong></td>
                                            <td>Dermatological (dermopathy, necrobiosis, etc.)<br>Cheiroarthropathy<br>Charcot neuroarthropathy<br>Fatty liver</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>

                        <h3 id="macrovascular">Symptoms of macrovascular disease</h3>
                        <p>People with diabetes have fewer, less severe symptomatic chest pains, possibly due to autonomic neuropathy leading to reduced deep pain sensation - so-called silent ischaemia. Peripheral vascular disease presents with claudication. A combination of peripheral neuropathy and peripheral vascular disease can lead to foot ulceration (Fig. 17.2).</p>

                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../assets/images/image-20251213-d522725e.jpeg" alt="Diabetic neuropathic ulcer" class="figure-image" loading="lazy">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption"><strong>Figure 17.2</strong> Diabetic neuropathic ulcer in a patient with Charcot neuroarthropathy.</figcaption>
                        </figure>

                        <h3 id="microvascular">Symptoms of microvascular disease</h3>
                        <p>Diabetic retinopathy and nephropathy are frequently asymptomatic until advanced. Diabetic neuropathy can manifest in a number of ways. Chronic peripheral sensory neuropathy is the commonest form, presenting with numbness or paraesthesiae, characteristically worse at night. Proximal motor neuropathy (diabetic amyotrophy) is characterized by severe thigh pain and weakness. Autonomic neuropathy can cause impotence, gustatory sweating, postural hypotension, and diabetic diarrhoea.</p>

                        <h3 id="hypoglycaemia">Hypoglycaemia</h3>
                        <p>Symptoms of hypoglycaemia include sweating, palpitations, hunger, agitation or blurred vision (sympathetic overactivation), followed by neuroglycopenic symptoms like confusion and coma. Loss of awareness of hypoglycaemia is a risk in long-standing diabetes.</p>
                    </section>

                    <section id="examination" class="content-section">
                        <h2>Examination of the diabetic patient</h2>
                        <p>Patients with diabetes can present with acute metabolic decompensation (DKA, HHS). In the non-acute setting, measurement of weight and height to ascertain BMI is of great importance.</p>

                        <div class="content-card">
                            <h4 class="nav-title" style="margin-bottom: var(--space-4);">Box 17.3 Body mass index (BMI)</h4>
                            <p><strong>BMI = weight (kg) / height (m)¬≤</strong></p>
                            <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 1rem;">
                                <div>
                                    <h5>Europeans</h5>
                                    <ul class="enhanced-list">
                                        <li class="list-item"><span class="list-marker"></span>Normal: 20-25</li>
                                        <li class="list-item"><span class="list-marker"></span>Overweight: 25.1-30</li>
                                        <li class="list-item"><span class="list-marker"></span>Obese: 30.1-35</li>
                                    </ul>
                                </div>
                                <div>
                                    <h5>Asians</h5>
                                    <ul class="enhanced-list">
                                        <li class="list-item"><span class="list-marker"></span>Normal: 18-23</li>
                                        <li class="list-item"><span class="list-marker"></span>Overweight: 23.1-28</li>
                                        <li class="list-item"><span class="list-marker"></span>Obese: 28.1-33</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="content-card">
                            <h4 class="nav-title">Box 17.4 The diabetic annual review</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><strong>History:</strong> Glucose diary, treatment, hypos, driving, vascular symptoms, smoking.</li>
                                <li class="list-item"><span class="list-marker"></span><strong>Examination:</strong> Weight/BMI, BP, injection sites, eyes, feet.</li>
                                <li class="list-item"><span class="list-marker"></span><strong>Tests:</strong> Renal/liver function, HbA1c, lipids, urine albumin.</li>
                            </ul>
                        </div>

                        <h3 id="skin-nails-hands">Skin, nails and hands</h3>
                        <p>Necrobiosis lipoidica diabeticorum (Fig. 17.3) presents as a painless red macule, usually over the anterior shin, healing with scarring. Granuloma annulare (Fig. 17.4) appears as pale, shiny rings. Acanthosis nigricans (Fig. 17.5) is a dark velvety thickening in axillae/neck indicating insulin resistance. Check injection sites for lipohypertrophy (Fig. 17.6) or lipoatrophy (Fig. 17.7).</p>

                        <div class="chapter-grid" style="grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));">
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-8ff71c06.jpeg" alt="Necrobiosis lipoidica diabeticorum" class="figure-image" loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption"><strong>Figure 17.3</strong> Necrobiosis lipoidica diabeticorum.</figcaption>
                            </figure>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-c1ce9751.jpeg" alt="Granuloma annulare" class="figure-image" loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption"><strong>Figure 17.4</strong> Granuloma annulare.</figcaption>
                            </figure>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-4fa317fa.jpeg" alt="Acanthosis nigricans" class="figure-image" loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption"><strong>Figure 17.5</strong> Acanthosis nigricans.</figcaption>
                            </figure>
                        </div>

                        <div class="chapter-grid" style="grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));">
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-005f89a2.jpeg" alt="Lipohypertrophy" class="figure-image" loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption"><strong>Figure 17.6</strong> Lipohypertrophy.</figcaption>
                            </figure>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-570e375e.jpeg" alt="Lipoatrophy" class="figure-image" loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption"><strong>Figure 17.7</strong> Lipoatrophy.</figcaption>
                            </figure>
                        </div>

                        <p>Diabetic cheiroarthropathy (stiff hand syndrome) is characterized by skin thickening and limited joint mobility, demonstrated by the prayer sign (Fig. 17.8).</p>

                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../assets/images/image-20251213-ba851773.jpeg" alt="Prayer sign" class="figure-image" loading="lazy">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption"><strong>Figure 17.8</strong> The prayer sign in diabetic cheiroarthropathy.</figcaption>
                        </figure>

                        <h3 id="eyes">Eyes</h3>
                        <p>Examination of the eyes is mandatory. Look for cataracts (Fig. 17.12) and perform funduscopy. Diabetic retinopathy is classified into non-proliferative (mild to severe) and proliferative.</p>

                        <div class="content-card">
                            <h4 class="nav-title" style="margin-bottom: var(--space-4);">Box 17.5 Characteristic features of diabetic retinopathy</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><strong>Non-proliferative:</strong> Microaneurysms, dot/blot haemorrhages, hard exudates, cotton wool spots, venous beading.</li>
                                <li class="list-item"><span class="list-marker"></span><strong>Proliferative:</strong> New vessels on disc (NVD) or elsewhere (NVE).</li>
                                <li class="list-item"><span class="list-marker"></span><strong>Maculopathy:</strong> Exudates or oedema near the macula.</li>
                            </ul>
                        </div>

                        <div class="chapter-grid" style="grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));">
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-4d7f966c.jpeg" alt="Background retinopathy" class="figure-image" loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption"><strong>Figure 17.13</strong> Background retinopathy (dot haemorrhages and microaneurysms).</figcaption>
                            </figure>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-208b275f.jpeg" alt="Preproliferative retinopathy" class="figure-image" loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption"><strong>Figure 17.14</strong> Preproliferative changes with multiple dot/blot haemorrhages and cotton wool spots.</figcaption>
                            </figure>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-c2de1b02.jpeg" alt="Exudative diabetic maculopathy" class="figure-image" loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption"><strong>Figure 17.17</strong> Exudative diabetic maculopathy.</figcaption>
                            </figure>
                        </div>

                        <h3 id="feet">Feet</h3>
                        <p>Examine for deformity, callus, infection, and ulceration. Nerve function should be assessed using a 10-g monofilament (Fig. 17.18) to test fine touch.</p>

                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../assets/images/image-20251213-35db7a84.jpeg" alt="Monofilament testing" class="figure-image" loading="lazy">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption"><strong>Figure 17.18</strong> Testing for neuropathy using a Semmes Weinstein monofilament.</figcaption>
                        </figure>
                    </section>

                    <section id="lipid-disorders" class="content-section">
                        <h2>Lipid disorders</h2>
                        <p>Lipid disorders are common and contribute significantly to cardiovascular disease. The diagnostic hallmark of familial hypercholesterolaemia is tendon xanthomata (Fig. 17.19). Xanthelasmata (eyelids) and corneal arcus are also seen but are less specific. Eruptive xanthomata (Fig. 17.20) are characteristic of hypertriglyceridaemia.</p>

                        <div class="chapter-grid" style="grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));">
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-495c5da9.jpeg" alt="Tendon xanthoma" class="figure-image" loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption"><strong>Figure 17.19</strong> Tendon xanthoma of the hands.</figcaption>
                            </figure>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-9ce93403.jpeg" alt="Eruptive xanthomata" class="figure-image" loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption"><strong>Figure 17.20</strong> Eruptive xanthomata in severe hypertriglyceridaemia.</figcaption>
                            </figure>
                        </div>
                    </section>

                </div>

                <!-- Bottom Navigation -->
                <nav class="document-nav document-nav--bottom" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="16-endocrine.html" class="nav-button nav-button--prev nav-button--large">
                            <span class="nav-icon">‚Üê</span>
                            <div class="nav-content">
                                <span class="nav-label">Previous</span>
                                <span class="nav-title">Endocrine Disorders</span>
                            </div>
                        </a>
                        
                        <a href="../index.html" class="nav-button nav-button--toc">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">All Topics</span>
                        </a>
                        
                        <a href="18-kidneys.html" class="nav-button nav-button--next nav-button--large">
                            <div class="nav-content">
                                <span class="nav-label">Next</span>
                                <span class="nav-title">Kidneys & Urinary Tract</span>
                            </div>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- v10 CRITICAL: Lightbox Modal (MANDATORY) -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- v10 CRITICAL: All Three JavaScript Files (MANDATORY) -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>